Chemoinformaics analysis of 4,12-DIHYDROXYHEXADECANOIC ACID
| Molecular Weight | 288.428 | nRot | 14 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 1 |
| Exact Molecular Weight | 288.23 | nRing | 0 |
| Solubility: LogS | -3.213 | nHRing | 0 |
| Solubility: LogP | 3.222 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 51.2654 |
| nHD | 3 | BPOL | 32.9706 |
| QED | 0.428 |
| Synth | 2.9 |
| Natural Product Likeliness | 0.869 |
| NR-PPAR-gamma | 0.981 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.275 |
| Pgp-sub | 0.344 |
| HIA | 0.24 |
| CACO-2 | -5.268 |
| MDCK | 0.0000596 |
| BBB | 0.588 |
| PPB | 0.894789 |
| VDSS | 0.429 |
| FU | 0.0698804 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.508 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.442 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.964 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.083 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.02 |
| CL | 10.687 |
| T12 | 0.812 |
| hERG | 0.025 |
| Ames | 0.006 |
| ROA | 0.002 |
| SkinSen | 0.63 |
| Carcinogencity | 0.06 |
| EI | 0.877 |
| Respiratory | 0.066 |
| NR-Aromatase | 0.034 |
| Antiviral | Yes |
| Prediction | 0.62892 |